Laskow D A, Curtis J J, Luke R G, Julian B A, Jones P, Deierhoi M H, Barber W H, Diethelm A G
Department of Surgery, University of Alabama Medical Center, Birmingham 35294.
Am J Med. 1990 May;88(5):497-502. doi: 10.1016/0002-9343(90)90429-h.
Cyclosporine is the mainstay of many immunosuppressant protocols, but confers a significant risk of nephrotoxicity. We sought to clarify the effects of cyclosporine on renal function in renal transplant recipients after induction of mild intravascular volume depletion.
Two groups of renal transplant patients with normal allograft function at least 6 months after transplantation whose immunosuppressive regimens differed only by the presence or absence of cyclosporine usage were enrolled in a 10-day in-hospital protocol. After a 3-day control period, intravascular volume depletion was produced by dietary restriction of sodium chloride for 4 days and the administration of furosemide. Creatinine and urea clearances, true glomerular filtration rate (GFR) (by radioisotope technique), and the fractional excretion of sodium were measured. The patients were subsequently given a high amount of sodium chloride by intravenous infusion (3.8 mEq/kg body weight/day) for 3 days and the studies were repeated.
Ten patients treated with azathioprine and prednisone (azathioprine-treated) and nine patients treated with cyclosporine, azathioprine, and prednisone (cyclosporine-treated) were enrolled. The two groups developed a similar degree of intravascular volume depletion; blood pressure did not change and urine flow rates did not differ between the groups throughout the protocol. The cyclosporine-treated patients showed significant decreases in GFR, creatinine clearance, and urea clearance, and increases in blood urea nitrogen (BUN) and percent urea reabsorption after intravascular volume depletion; these findings resolved after challenge with the sodium chloride load. In contrast, the azathioprine-treated patients' BUN, urea clearance, GFR, and creatinine clearance did not significantly change throughout the protocol. The decrease in the fractional excretion of sodium after intravascular volume depletion was significantly greater in the cyclosporine-treated patients.
Cyclosporine predisposes to acute reversible nephrotoxicity by compromising the renal compensatory mechanisms. Proximal tubular function, as manifested by urea and sodium reabsorption, remains intact.
环孢素是许多免疫抑制方案的主要药物,但具有显著的肾毒性风险。我们试图阐明轻度血管内容量减少诱导后环孢素对肾移植受者肾功能的影响。
两组移植后至少6个月移植肾功能正常的肾移植患者,其免疫抑制方案仅因是否使用环孢素而不同,纳入一项为期10天的住院方案。在3天的对照期后,通过限制氯化钠饮食4天并给予呋塞米来造成血管内容量减少。测量肌酐和尿素清除率、真实肾小球滤过率(GFR)(通过放射性同位素技术)以及钠的分数排泄。随后,通过静脉输注给予患者大量氯化钠(3.8 mEq/千克体重/天),持续3天,并重复进行研究。
纳入了10例接受硫唑嘌呤和泼尼松治疗的患者(硫唑嘌呤治疗组)以及9例接受环孢素、硫唑嘌呤和泼尼松治疗的患者(环孢素治疗组)。两组出现了相似程度的血管内容量减少;在整个方案过程中,两组的血压没有变化,尿流率也没有差异。血管内容量减少后,环孢素治疗组患者的GFR、肌酐清除率和尿素清除率显著降低,血尿素氮(BUN)和尿素重吸收百分比增加;在给予氯化钠负荷后,这些发现得到缓解。相比之下,硫唑嘌呤治疗组患者的BUN、尿素清除率、GFR和肌酐清除率在整个方案过程中没有显著变化。血管内容量减少后,环孢素治疗组患者钠的分数排泄降低更为显著。
环孢素通过损害肾脏代偿机制易导致急性可逆性肾毒性。以尿素和钠重吸收表现的近端肾小管功能保持完整。